Micellar electrokinetic capillary chromatography for therapeutic drug monitoring of zonisamide.
The simultaneous determination of zonisamide, a new type of antiepileptic drug, and the typical antiepileptic drugs phenobarbital, phenytoin and carbamazepine in human serum was developed using micellar electrokinetic capillary chromatography (MECC) with a diode array detector. A high correlation was revealed between the zonisamide levels in human serum obtained by MECC and those obtained by high-performance liquid chromatography (r=0.981). The serum levels of phenobarbital, phenytoin and carbamazepine determined by MECC were almost equal to those obtained by fluorescence polarization immunoassay. The reproducibility of separation and quantification with MECC analysis was appropriate for the intra- and inter-day assay coefficients. Therefore, the MECC method established here could provide a simple and efficient therapeutic drug monitoring method for antiepileptic drugs in patients, especially those treated with a combination of zonisamide and other antiepileptic drugs.
Makino
K
K
Department of Hospital Pharmacy, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Goto
Y
Y
Sueyasu
M
M
Futagami
K
K
Kataoka
Y
Y
Oishi
R
R
D000927:Anticonvulsants / Q000097:blood*; D002220:Carbamazepine / Q000097:blood; D002851:Chromatography, High Pressure Liquid; D016903:Drug Monitoring; D019075:Electrophoresis, Capillary; D016231:Fluorescence Polarization Immunoassay; D006801:Humans; D007555:Isoxazoles / Q000097:blood*; D010634:Phenobarbital / Q000097:blood; D010672:Phenytoin / Q000097:blood; D000078305:Zonisamide
D000927:Anticonvulsants; D007555:Isoxazoles; D002220:Carbamazepine; D000078305:Zonisamide; D010672:Phenytoin; D010634:Phenobarbital